Crossing the blood-brain barrier with antibodies

The blood-brain barrier seems impenetrable, but new therapeutic antibodies may creep past its defenses. 

Scientists once believed that the central nervous system was inaccessible to antibody therapeutics. Now emerging evidence suggests that naturally occurring antibodies in the body may sneak past the blood-brain barrier to target and destroy abnormal proteins in the brain.

Download this poster from Drug Discovery News to learn how scientists are developing innovative therapeutic antibodies capable of crossing the blood-brain barrier for treating neurological diseases.

Supported by